VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $568,000 | -23.8% | 3,186 | -5.0% | 0.16% | -16.8% |
| Q2 2015 | $745,000 | -40.4% | 3,353 | -46.7% | 0.19% | -39.6% |
| Q1 2015 | $1,249,000 | +39.2% | 6,292 | +0.4% | 0.32% | +36.8% |
| Q4 2014 | $897,000 | +9.0% | 6,270 | 0.0% | 0.23% | +4.1% |
| Q3 2014 | $823,000 | +4.0% | 6,270 | 0.0% | 0.22% | +29.1% |
| Q2 2014 | $791,000 | -4.4% | 6,270 | 0.0% | 0.17% | -9.5% |
| Q1 2014 | $827,000 | -20.4% | 6,270 | -29.2% | 0.19% | -32.6% |
| Q4 2013 | $1,039,000 | +12.6% | 8,850 | 0.0% | 0.28% | +2.5% |
| Q3 2013 | $923,000 | +14.9% | 8,850 | -5.1% | 0.28% | +3.4% |
| Q2 2013 | $803,000 | – | 9,330 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |